Adherence to guidelineâ€recommended hepatitis B virus (HBV) care is suboptimal. We hypothesized that national hepatitis C eradication efforts during the era from 2015â€2017 would improve the quality of care for cHBV given increased recognition and specialty referrals for liver disease. The study described herein is a retrospective cohort study of veterans with at least one positive HBsAg (HBsAg+) result from January 1, 2003 to December 31st, 2017 using the VA Corporate Data Warehouse (CDW) analyzed by era (2003â€2004, 2005â€2009, 2010â€2014, 2015â€2017). Relevant covariates such as HCV coinfection, demographics, cirrhosis, and baseline laboratory testing were obtained through previously validated approaches. We evaluated completion of process measures within 2 years of the index HBsAg+ result: specialty care referral; testing of ALT, HBVâ€DNA, HBeAg, antiâ€HBe; testing for coinfection and/or vaccination for HAV, HCV, HDV, and HIV; and hepatocellular carcinoma (HCC) surveillance among those meeting criteria.